New User? Sign Up | Sign In

Insider Trading - Aligos Therapeutics Inc. (ALGS)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

ALGS Insider Trading Transactions for Aligos Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-10-20
Purchase
2020-10-20
4:58 pm
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
200,000 $15 $3,000,000 862,444
(Indirect
Direct)
View
2020-10-20
Purchase
2020-10-20
4:59 pm
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
550,000 $15 $8,250,000 430,372
(Indirect)
View
2020-10-20
Purchase
2020-10-20
5:00 pm
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
200,000 $15 $3,000,000 862,444
(Indirect)
View
2020-10-20
Purchase
2020-10-22
4:31 pm
Aligos Therapeutics Inc. ALGS Novo Holdings A/S
10% Owner
200,000 $15 $3,000,000 2,614,563
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
163,842 $0 163,842
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
13,559 $0 13,559
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
13,559 $0 13,559
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
50,781 $0 214,623
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
3,359 $0 16,918
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
3,359 $0 16,918
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
21,724 $0 236,347
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
1,437 $0 18,355
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
1,437 $0 18,355
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
163,842 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
13,559 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
13,559 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
50,781 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
3,359 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
3,359 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
21,724 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
1,437 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
1,437 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
41,016 $0 41,016
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
122,601 $0 122,601
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
13,671 $0 13,671
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
13,671 $0 13,671
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
50,712 $0 91,728
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
3,394 $0 17,065
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
3,394 $0 17,065
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
21,695 $0 113,423
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
1,452 $0 18,517
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
1,452 $0 18,517
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
41,016 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
122,601 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
13,671 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
13,671 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
50,712 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
3,394 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
3,394 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
21,695 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
1,452 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
1,452 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Nuechterlein Carole
Director
2,145,991 $0 2,145,991
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Nuechterlein Carole
Director
662,799 $0 2,808,790
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Nuechterlein Carole
Director
283,550 $0 3,092,340
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Nuechterlein Carole
Director
2,145,991 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Nuechterlein Carole
Director
662,799 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Nuechterlein Carole
Director
283,550 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:56 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Quan Lucinda Y.
See Remarks
6,835 $0 6,835
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:56 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Quan Lucinda Y.
See Remarks
1,697 $0 8,532
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:56 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Quan Lucinda Y.
See Remarks
726 $0 9,258
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:56 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Quan Lucinda Y.
See Remarks
6,835 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:56 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Quan Lucinda Y.
See Remarks
1,697 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:56 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Quan Lucinda Y.
See Remarks
726 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:57 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Symons Julian A.
See Remarks
13,671 $0 389,218
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:57 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Symons Julian A.
See Remarks
3,394 $0 392,612
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:57 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Symons Julian A.
See Remarks
1,452 $0 394,064
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:57 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Symons Julian A.
See Remarks
13,671 $0 0
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:57 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Symons Julian A.
See Remarks
3,394 $0 0
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:57 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Symons Julian A.
See Remarks
1,452 $0 0
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
2,145,991 $0 2,145,991
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
198,839 $0 2,344,830
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
85,065 $0 2,429,895
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
463,959 $0 463,959
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
198,485 $0 662,444
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
2,145,991 $0 0
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
198,839 $0 0
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
463,959 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
85,065 $0 0
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
198,485 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
1,885,611 $0 1,885,611
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
523,726 $0 2,409,337
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
224,054 $0 2,633,391
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
260,380 $0 260,380
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
72,320 $0 332,700
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
30,939 $0 363,639
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
1,885,611 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
260,380 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
523,726 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
72,320 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
224,054 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
30,939 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
2,145,991 $0 2,145,991
(Indirect)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
198,839 $0 2,344,830
(Indirect)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
85,065 $0 2,429,895
(Indirect)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
463,959 $0 463,959
(Indirect)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
198,485 $0 662,444
(Indirect)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
2,145,991 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
198,839 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
463,959 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
85,065 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
198,485 $0 0
(Indirect)
View
2020-10-20
Conversion
2020-10-22
4:12 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
1,335,048 $0 1,335,048
(Direct)
View
2020-10-20
Conversion
2020-10-22
4:12 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
571,143 $0 1,906,191
(Direct)
View
2020-10-20
Conversion
2020-10-22
4:12 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
1,335,048 $0 0
(Direct)
View
2020-10-20
Conversion
2020-10-22
4:12 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
571,143 $0 0
(Direct)
View
2020-10-20
Conversion
2020-10-22
4:31 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Novo Holdings A/S
10% Owner
2,414,563 $0 2,414,563
(Direct)
View
2020-10-20
Conversion
2020-10-22
4:31 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Novo Holdings A/S
10% Owner
1,609,493 $0 0
(Direct)
View
2020-10-20
Conversion
2020-10-22
4:31 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Novo Holdings A/S
10% Owner
563,851 $0 0
(Direct)
View
2020-10-20
Conversion
2020-10-22
4:31 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Novo Holdings A/S
10% Owner
241,219 $0 0
(Direct)
View
2020-12-01
Option Award
2020-12-03
8:03 pm
N/A
2030-12-01
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
450,000 $0 450,000
(Direct)
View
2020-12-01
Option Award
2020-12-03
8:03 pm
N/A
2030-12-01
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
300,000 $0 300,000
(Direct)
View
2020-12-01
Option Award
2020-12-03
8:04 pm
N/A
2030-12-01
Aligos Therapeutics Inc. ALGS Quan Lucinda Y.
See Remarks
200,000 $0 200,000
(Direct)
View
2020-12-01
Option Award
2020-12-03
8:04 pm
N/A
2030-12-01
Aligos Therapeutics Inc. ALGS Calhoun Lesley Ann
See Remarks
176,237 $0 176,237
(Direct)
View
2020-12-01
Option Award
2020-12-03
8:05 pm
N/A
2030-12-01
Aligos Therapeutics Inc. ALGS Symons Julian A.
See Remarks
200,000 $0 200,000
(Direct)
View
2021-04-26
Option Award
2021-04-27
4:42 pm
N/A
2031-04-26
Aligos Therapeutics Inc. ALGS Scopa James Paul
Director
30,000 $0 30,000
(Direct)
View
2021-04-26
Other
2021-04-28
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
485,979 $0 1,943,916
(Indirect)
View
2021-04-26
Other
2021-04-28
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
9,720 $0 9,720
(Indirect)
View
2021-04-26
Other
2021-04-28
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
9,720 $0 0
(Indirect)
View
2021-04-26
Other
2021-04-28
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
8,385 $0 8,385
(Indirect)
View
2021-04-26
Other
2021-04-28
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
8,385 $0 0
(Indirect)
View
2021-04-26
Other
2021-04-28
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
2,226 $0 2,226
(Direct)
View